Assertio Holdings, Inc. To Acquire Spectrum Pharmaceuticals, Inc. In All Stock And CVR Transaction; Spectrum Stockholders To Receive Upfront Consideration Of 0.1783 ASRT Shares Per SPPI Share Plus One CVR For Potential Consideration Up To $1.34/Share
Author: Benzinga Newsdesk | April 25, 2023 06:06am